Michael P. Henighan
Chief Financial Officer
financial operations
WaferGen Bio systems
United States of America
Biography
Michael P. Henighan joined WaferGen in August 2014 as Chief Financial Officer. Prior to joining Wafergen, Michael was a founder and Chief Financial Officer of Aplegen, Inc. from February 2011 through August 2015. Prior to joining Aplegen Michael was the Alpha Innotech, Inc., a publicly traded life science imaging trading company, Chief Financial Officer from August 2008 to October 2009 and Corporate Controller from May of 2008 to August 2008, Michael was Vice President and Corporate Controller at HemoSense, Inc., a publicly traded medical device company, from May 2005 to May 2008 and Corporate Controller at Cholestech Corp., a publicly traded medical device company, from July 1997 to May 2005. Prior to 1997, he also held senior management positions with Solectron, Applied Biosystems, and Motorola. Michael earned his BS in Accounting from California State University, Los Angeles.
Research Interest
financial operations
